Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive

Clinical trial NCT06652139 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06652139
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2024-11-01
Primary completion: 2026-11-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.